Full Spectrum Medicinals

Full Spectrum Medicinals is a Canadian biotechnology company specializing in the extraction, formulation, and research of medical cannabis products. The company was notably recognized for holding a Dealer's License under the Controlled Drugs and Substances Act, which permitted the research, development, and international export of cannabinoid-based oils and concentrates. In 2018, the company was acquired by The Green Organic Dutchman (TGOD) to serve as a strategic hub for extraction and the development of advanced cannabis-infused products. Its operations focused on high-quality, organic extraction processes to support therapeutic applications in pain management and other chronic conditions. Following the acquisition, its capabilities were integrated into the parent company's global medical cannabis strategy.